494: Antibiotic alternative for the treatment of nontuberculous mycobacteria infections in cystic fibrosis
Gespeichert in:
| Autor*in: |
McDonald, R. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
2021 |
|---|
| Umfang: |
2 |
|---|
| Übergeordnetes Werk: |
Enthalten in: In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system - Gök, Mehmet Koray ELSEVIER, 2019, the official journal of the European Cystic Fibrosis Society, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:20 ; year:2021 ; pages:233-234 ; extent:2 |
| Links: |
|---|
| DOI / URN: |
10.1016/S1569-1993(21)01918-4 |
|---|
| Katalog-ID: |
ELV055580890 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV055580890 | ||
| 003 | DE-627 | ||
| 005 | 20230624222456.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220105s2021 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1016/S1569-1993(21)01918-4 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001551.pica |
| 035 | |a (DE-627)ELV055580890 | ||
| 035 | |a (ELSEVIER)S1569-1993(21)01918-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 670 |q VZ |
| 084 | |a 35.80 |2 bkl | ||
| 100 | 1 | |a McDonald, R. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 494: Antibiotic alternative for the treatment of nontuberculous mycobacteria infections in cystic fibrosis |
| 264 | 1 | |c 2021 | |
| 300 | |a 2 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 700 | 1 | |a Chambers, M. |4 oth | |
| 700 | 1 | |a Ahonen, M. |4 oth | |
| 700 | 1 | |a Simons, J. |4 oth | |
| 700 | 1 | |a Ordway, D. |4 oth | |
| 700 | 1 | |a Schoenfisch, M. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Gök, Mehmet Koray ELSEVIER |t In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system |d 2019 |d the official journal of the European Cystic Fibrosis Society |g Amsterdam [u.a.] |w (DE-627)ELV002341220 |
| 773 | 1 | 8 | |g volume:20 |g year:2021 |g pages:233-234 |g extent:2 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S1569-1993(21)01918-4 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 35.80 |j Makromolekulare Chemie |q VZ |
| 951 | |a AR | ||
| 952 | |d 20 |j 2021 |h 233-234 |g 2 |y 20.2021, S233-, (2 S.) | ||
| author_variant |
r m rm |
|---|---|
| matchkey_str |
mcdonaldrchambersmahonenmsimonsjordwayds:2021----:9atboiatraieoteramnonnueclumcbceii |
| hierarchy_sort_str |
2021 |
| bklnumber |
35.80 |
| publishDate |
2021 |
| allfields |
10.1016/S1569-1993(21)01918-4 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001551.pica (DE-627)ELV055580890 (ELSEVIER)S1569-1993(21)01918-4 DE-627 ger DE-627 rakwb 670 VZ 35.80 bkl McDonald, R. verfasserin aut 494: Antibiotic alternative for the treatment of nontuberculous mycobacteria infections in cystic fibrosis 2021 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Chambers, M. oth Ahonen, M. oth Simons, J. oth Ordway, D. oth Schoenfisch, M. oth Enthalten in Elsevier Science Gök, Mehmet Koray ELSEVIER In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system 2019 the official journal of the European Cystic Fibrosis Society Amsterdam [u.a.] (DE-627)ELV002341220 volume:20 year:2021 pages:233-234 extent:2 https://doi.org/10.1016/S1569-1993(21)01918-4 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 35.80 Makromolekulare Chemie VZ AR 20 2021 233-234 2 20.2021, S233-, (2 S.) |
| spelling |
10.1016/S1569-1993(21)01918-4 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001551.pica (DE-627)ELV055580890 (ELSEVIER)S1569-1993(21)01918-4 DE-627 ger DE-627 rakwb 670 VZ 35.80 bkl McDonald, R. verfasserin aut 494: Antibiotic alternative for the treatment of nontuberculous mycobacteria infections in cystic fibrosis 2021 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Chambers, M. oth Ahonen, M. oth Simons, J. oth Ordway, D. oth Schoenfisch, M. oth Enthalten in Elsevier Science Gök, Mehmet Koray ELSEVIER In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system 2019 the official journal of the European Cystic Fibrosis Society Amsterdam [u.a.] (DE-627)ELV002341220 volume:20 year:2021 pages:233-234 extent:2 https://doi.org/10.1016/S1569-1993(21)01918-4 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 35.80 Makromolekulare Chemie VZ AR 20 2021 233-234 2 20.2021, S233-, (2 S.) |
| allfields_unstemmed |
10.1016/S1569-1993(21)01918-4 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001551.pica (DE-627)ELV055580890 (ELSEVIER)S1569-1993(21)01918-4 DE-627 ger DE-627 rakwb 670 VZ 35.80 bkl McDonald, R. verfasserin aut 494: Antibiotic alternative for the treatment of nontuberculous mycobacteria infections in cystic fibrosis 2021 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Chambers, M. oth Ahonen, M. oth Simons, J. oth Ordway, D. oth Schoenfisch, M. oth Enthalten in Elsevier Science Gök, Mehmet Koray ELSEVIER In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system 2019 the official journal of the European Cystic Fibrosis Society Amsterdam [u.a.] (DE-627)ELV002341220 volume:20 year:2021 pages:233-234 extent:2 https://doi.org/10.1016/S1569-1993(21)01918-4 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 35.80 Makromolekulare Chemie VZ AR 20 2021 233-234 2 20.2021, S233-, (2 S.) |
| allfieldsGer |
10.1016/S1569-1993(21)01918-4 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001551.pica (DE-627)ELV055580890 (ELSEVIER)S1569-1993(21)01918-4 DE-627 ger DE-627 rakwb 670 VZ 35.80 bkl McDonald, R. verfasserin aut 494: Antibiotic alternative for the treatment of nontuberculous mycobacteria infections in cystic fibrosis 2021 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Chambers, M. oth Ahonen, M. oth Simons, J. oth Ordway, D. oth Schoenfisch, M. oth Enthalten in Elsevier Science Gök, Mehmet Koray ELSEVIER In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system 2019 the official journal of the European Cystic Fibrosis Society Amsterdam [u.a.] (DE-627)ELV002341220 volume:20 year:2021 pages:233-234 extent:2 https://doi.org/10.1016/S1569-1993(21)01918-4 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 35.80 Makromolekulare Chemie VZ AR 20 2021 233-234 2 20.2021, S233-, (2 S.) |
| allfieldsSound |
10.1016/S1569-1993(21)01918-4 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001551.pica (DE-627)ELV055580890 (ELSEVIER)S1569-1993(21)01918-4 DE-627 ger DE-627 rakwb 670 VZ 35.80 bkl McDonald, R. verfasserin aut 494: Antibiotic alternative for the treatment of nontuberculous mycobacteria infections in cystic fibrosis 2021 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Chambers, M. oth Ahonen, M. oth Simons, J. oth Ordway, D. oth Schoenfisch, M. oth Enthalten in Elsevier Science Gök, Mehmet Koray ELSEVIER In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system 2019 the official journal of the European Cystic Fibrosis Society Amsterdam [u.a.] (DE-627)ELV002341220 volume:20 year:2021 pages:233-234 extent:2 https://doi.org/10.1016/S1569-1993(21)01918-4 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 35.80 Makromolekulare Chemie VZ AR 20 2021 233-234 2 20.2021, S233-, (2 S.) |
| source |
Enthalten in In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system Amsterdam [u.a.] volume:20 year:2021 pages:233-234 extent:2 |
| sourceStr |
Enthalten in In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system Amsterdam [u.a.] volume:20 year:2021 pages:233-234 extent:2 |
| format_phy_str_mv |
Article |
| bklname |
Makromolekulare Chemie |
| institution |
findex.gbv.de |
| dewey-raw |
670 |
| isfreeaccess_bool |
false |
| container_title |
In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system |
| authorswithroles_txt_mv |
McDonald, R. @@aut@@ Chambers, M. @@oth@@ Ahonen, M. @@oth@@ Simons, J. @@oth@@ Ordway, D. @@oth@@ Schoenfisch, M. @@oth@@ |
| publishDateDaySort_date |
2021-01-01T00:00:00Z |
| hierarchy_top_id |
ELV002341220 |
| dewey-sort |
3670 |
| id |
ELV055580890 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV055580890</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624222456.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220105s2021 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S1569-1993(21)01918-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001551.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV055580890</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1569-1993(21)01918-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">670</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">McDonald, R.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">494: Antibiotic alternative for the treatment of nontuberculous mycobacteria infections in cystic fibrosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">2</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chambers, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ahonen, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Simons, J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ordway, D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schoenfisch, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Gök, Mehmet Koray ELSEVIER</subfield><subfield code="t">In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system</subfield><subfield code="d">2019</subfield><subfield code="d">the official journal of the European Cystic Fibrosis Society</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002341220</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:20</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:233-234</subfield><subfield code="g">extent:2</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S1569-1993(21)01918-4</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.80</subfield><subfield code="j">Makromolekulare Chemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">20</subfield><subfield code="j">2021</subfield><subfield code="h">233-234</subfield><subfield code="g">2</subfield><subfield code="y">20.2021, S233-, (2 S.)</subfield></datafield></record></collection>
|
| author |
McDonald, R. |
| spellingShingle |
McDonald, R. ddc 670 bkl 35.80 494: Antibiotic alternative for the treatment of nontuberculous mycobacteria infections in cystic fibrosis |
| authorStr |
McDonald, R. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV002341220 |
| format |
electronic Article |
| dewey-ones |
670 - Manufacturing |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
670 VZ 35.80 bkl 494: Antibiotic alternative for the treatment of nontuberculous mycobacteria infections in cystic fibrosis |
| topic |
ddc 670 bkl 35.80 |
| topic_unstemmed |
ddc 670 bkl 35.80 |
| topic_browse |
ddc 670 bkl 35.80 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
m c mc m a ma j s js d o do m s ms |
| hierarchy_parent_title |
In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system |
| hierarchy_parent_id |
ELV002341220 |
| dewey-tens |
670 - Manufacturing |
| hierarchy_top_title |
In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV002341220 |
| title |
494: Antibiotic alternative for the treatment of nontuberculous mycobacteria infections in cystic fibrosis |
| ctrlnum |
(DE-627)ELV055580890 (ELSEVIER)S1569-1993(21)01918-4 |
| title_full |
494: Antibiotic alternative for the treatment of nontuberculous mycobacteria infections in cystic fibrosis |
| author_sort |
McDonald, R. |
| journal |
In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system |
| journalStr |
In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
zzz |
| container_start_page |
233 |
| author_browse |
McDonald, R. |
| container_volume |
20 |
| physical |
2 |
| class |
670 VZ 35.80 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
McDonald, R. |
| doi_str_mv |
10.1016/S1569-1993(21)01918-4 |
| dewey-full |
670 |
| title_sort |
494: antibiotic alternative for the treatment of nontuberculous mycobacteria infections in cystic fibrosis |
| title_auth |
494: Antibiotic alternative for the treatment of nontuberculous mycobacteria infections in cystic fibrosis |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
494: Antibiotic alternative for the treatment of nontuberculous mycobacteria infections in cystic fibrosis |
| url |
https://doi.org/10.1016/S1569-1993(21)01918-4 |
| remote_bool |
true |
| author2 |
Chambers, M. Ahonen, M. Simons, J. Ordway, D. Schoenfisch, M. |
| author2Str |
Chambers, M. Ahonen, M. Simons, J. Ordway, D. Schoenfisch, M. |
| ppnlink |
ELV002341220 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth |
| doi_str |
10.1016/S1569-1993(21)01918-4 |
| up_date |
2024-07-06T17:56:36.104Z |
| _version_ |
1803853334949396480 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV055580890</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624222456.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220105s2021 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S1569-1993(21)01918-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001551.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV055580890</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1569-1993(21)01918-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">670</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">McDonald, R.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">494: Antibiotic alternative for the treatment of nontuberculous mycobacteria infections in cystic fibrosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">2</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chambers, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ahonen, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Simons, J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ordway, D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schoenfisch, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Gök, Mehmet Koray ELSEVIER</subfield><subfield code="t">In vitro evaluation of synergistic effect of primary and tertiary amino groups in chitosan used as a non-viral gene carrier system</subfield><subfield code="d">2019</subfield><subfield code="d">the official journal of the European Cystic Fibrosis Society</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002341220</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:20</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:233-234</subfield><subfield code="g">extent:2</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S1569-1993(21)01918-4</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.80</subfield><subfield code="j">Makromolekulare Chemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">20</subfield><subfield code="j">2021</subfield><subfield code="h">233-234</subfield><subfield code="g">2</subfield><subfield code="y">20.2021, S233-, (2 S.)</subfield></datafield></record></collection>
|
| score |
7.4026117 |